Novel radiolabeled ligand, Para-chloro-2-[<sup>18</sup>F]fluoroethyletomidate (CETO) compared to [<sup>11</sup>C]metomidate-PET (MTO) for the lateralisation of primary aldosteronism (PA)Emily Goodchild, Morris J. Brown, Anju Sadhev et al.|Endocrine Abstracts|2022Cited by 1
OR34-07 Prospective Multicentre Study Comparing 11C-metomidate PET CT with Adrenal Vein Sampling (AVS) in the Detection of Unilateral Aldosterone-Producing Adenomas (APAs)Xilin Wu, Morris J. Brown, Mark Gurnell et al.|Journal of the Endocrine Society|2020Cited by 0
Complete clinical cure of primary aldosteronism (PA) is predictable and sustained for at least two yearsEmily Goodchild, Morris J. Brown, Emmanuel Savage et al.|Endocrine Abstracts|2022Cited by 0
FRI156 Novel Radiolabeled Ligand, Para-chloro-2-[18F]fluoroethyletomidate (CETO) Is Equivalent To [11C]metomidate-PET (MTO) For The Lateralisation Of Primary Aldosteronism (PA)Emily Goodchild, Morris J. Brown, István Boros et al.|Journal of the Endocrine Society|2023Cited by 0